- Home
- KNSA vs SKWD Comparison
KNSA vs SKWD Comparison
Compare KNSA & SKWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KNSA | SKWD |
|---|---|---|
| Founded | 2015 | 2007 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 2018 | 2023 |
Fundamental Metrics
Financial Performance| Metric | KNSA | SKWD |
|---|---|---|
| Price | $43.54 | $52.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 12 |
| Target Price | $51.33 | ★ $65.30 |
| AVG Volume (30 Days) | ★ 399.9K | 384.2K |
| Earning Date | 10-28-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | 0.47 | ★ 3.37 |
| Revenue | $597,973,000.00 | ★ $1,335,358,000.00 |
| Revenue This Year | $62.63 | $24.41 |
| Revenue Next Year | $29.93 | $30.82 |
| P/E Ratio | $92.52 | ★ $15.15 |
| Revenue Growth | ★ 55.68 | 22.27 |
| 52 Week Low | $17.82 | $41.28 |
| 52 Week High | $43.73 | $65.05 |
Technical Indicators
Market Signals| Indicator | KNSA | SKWD |
|---|---|---|
| Relative Strength Index (RSI) | 67.33 | 64.75 |
| Support Level | $40.77 | $48.50 |
| Resistance Level | $42.32 | $51.84 |
| Average True Range (ATR) | 1.45 | 1.63 |
| MACD | 0.12 | 0.45 |
| Stochastic Oscillator | 81.29 | 93.33 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About SKWD Skyward Specialty Insurance Group Inc.
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.